B34.1 - Hantavirus (cardio)-pulmonary syndrome
ICD-10 B34.1 is a billable code used to indicate a diagnosis of b34.1 - hantavirus (cardio)-pulmonary syndrome.
Hantavirus cardio-pulmonary syndrome (HCPS) is a severe respiratory illness caused by hantaviruses, primarily transmitted to humans through contact with infected rodent excreta, urine, or saliva. The disease is characterized by a sudden onset of fever, myalgia, and gastrointestinal symptoms, which can progress to severe pulmonary edema and respiratory failure. The incubation period typically ranges from 1 to 5 weeks following exposure. Diagnostic methods include serological tests for hantavirus antibodies, PCR assays to detect viral RNA, and clinical evaluation of symptoms. Early recognition and supportive care are crucial, as there are currently no specific antiviral treatments approved for HCPS. Management focuses on maintaining oxygenation and fluid balance, with mechanical ventilation required in severe cases. The prognosis varies, with a higher mortality rate in patients who develop severe respiratory distress.
Detailed patient history, exposure assessment, and laboratory results.
Patients presenting with respiratory symptoms after potential rodent exposure.
Ensure thorough documentation of serological and PCR test results.
Clinical assessment of respiratory function and treatment interventions.
Patients with acute respiratory distress requiring hospitalization.
Document all interventions and patient responses to treatment.
Used to confirm diagnosis in suspected cases of HCPS.
Document the reason for testing and clinical findings.
Infectious disease specialists should ensure comprehensive documentation of exposure history.
Common symptoms include fever, myalgia, gastrointestinal symptoms, and severe respiratory distress. Symptoms can progress rapidly, leading to pulmonary edema.